IN2012DN01449A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01449A IN2012DN01449A IN1449DEN2012A IN2012DN01449A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A IN 1449DEN2012 A IN1449DEN2012 A IN 1449DEN2012A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A
- Authority
- IN
- India
- Prior art keywords
- diagnostic
- blood vessels
- conditions associated
- pathological conditions
- cancerous tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200900879 | 2009-07-17 | ||
US30078210P | 2010-02-02 | 2010-02-02 | |
EP10152394 | 2010-02-02 | ||
PCT/DK2010/050192 WO2011006510A1 (en) | 2009-07-17 | 2010-07-16 | Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01449A true IN2012DN01449A (ru) | 2015-06-05 |
Family
ID=43448962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1449DEN2012 IN2012DN01449A (ru) | 2009-07-17 | 2010-07-16 |
Country Status (7)
Country | Link |
---|---|
US (2) | US8920775B2 (ru) |
EP (1) | EP2453927B1 (ru) |
JP (1) | JP5872466B2 (ru) |
AU (1) | AU2010272957B2 (ru) |
CA (1) | CA2768444A1 (ru) |
IN (1) | IN2012DN01449A (ru) |
WO (1) | WO2011006510A1 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011344865B2 (en) | 2010-12-14 | 2017-03-09 | Rigshospitalet | Entrapment of radionuclides in nanoparticle compositions |
KR20150050524A (ko) * | 2012-04-17 | 2015-05-08 | 메리맥 파마슈티컬즈, 인크. | 비침습적 이미징을 위한 조성물 및 방법 |
US9480759B2 (en) * | 2012-11-21 | 2016-11-01 | Serene, Llc | Tin-117m somatostatin receptor binding compounds and methods |
US20160022842A1 (en) * | 2013-03-11 | 2016-01-28 | Wayne State University | Formation and uses of europium |
WO2017027064A1 (en) | 2015-08-12 | 2017-02-16 | The General Hospital Corporation | 8-hydroxyquinoline derivatives as diagnostic and therapeutic agents |
CA3015663A1 (en) * | 2016-03-07 | 2017-09-14 | Memorial Sloan Kettering Cancer Center | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use |
EP3849515A1 (en) * | 2018-09-11 | 2021-07-21 | Memorial Sloan Kettering Cancer Center | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use |
US11478493B2 (en) * | 2019-03-08 | 2022-10-25 | University Of South Carolina | Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers |
WO2023240135A2 (en) | 2022-06-07 | 2023-12-14 | Actinium Pharmaceuticals, Inc. | Bifunctional chelators and conjugates |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3880691T2 (de) | 1987-11-04 | 1993-08-12 | Vestar Inc | Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren. |
US5688488A (en) | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5525232A (en) | 1990-03-02 | 1996-06-11 | The Liposome Company, Inc. | Method for entrapment of cationic species in lemellar vesicles |
JPH075561B2 (ja) | 1991-12-17 | 1995-01-25 | 工業技術院長 | α−アミノ酸のジアミド誘導体 |
US5837282A (en) * | 1996-10-30 | 1998-11-17 | University Of British Columbia | Ionophore-mediated liposome loading |
US6306393B1 (en) * | 1997-03-24 | 2001-10-23 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
US5945502A (en) * | 1997-11-13 | 1999-08-31 | Xerox Corporation | Electroluminescent polymer compositions and processes thereof |
NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
DE10012782A1 (de) * | 2000-03-16 | 2001-09-20 | Boellhoff Gmbh | Verbindungsanordnung zum Anbringen eines Befestigungselementes an einem Bauteil |
WO2004082627A2 (en) * | 2003-03-18 | 2004-09-30 | Ethicon, Inc. | ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
WO2004082626A2 (en) | 2003-03-18 | 2004-09-30 | Ethicon, Inc. | Aromatase inhibitor diagnosis and therapy |
US20060040980A1 (en) | 2004-08-20 | 2006-02-23 | Lind Stuart E | Ionophores as cancer chemotherapeutic agents |
US8349360B2 (en) * | 2004-10-06 | 2013-01-08 | Bc Cancer Agency | Liposomes with improved drug retention for treatment of cancer |
GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
ITMI20050328A1 (it) | 2005-03-03 | 2006-09-04 | Univ Degli Studi Milano | Composti peptidomimetrici e preparazione di derivati biologicamente attivi |
WO2008105773A2 (en) * | 2006-03-31 | 2008-09-04 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
TW200922630A (en) | 2007-09-26 | 2009-06-01 | Nat Health Research Institutes | Liposome compositions useful for tumor imaging and treatment |
WO2009140215A2 (en) | 2008-05-11 | 2009-11-19 | Geraghty, Erin | Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds |
CA2852564A1 (en) * | 2011-10-31 | 2013-05-10 | Mallinckrodt Llc | Combinational liposome compositions for cancer therapy |
-
2010
- 2010-07-16 AU AU2010272957A patent/AU2010272957B2/en not_active Ceased
- 2010-07-16 WO PCT/DK2010/050192 patent/WO2011006510A1/en active Application Filing
- 2010-07-16 EP EP10799456.8A patent/EP2453927B1/en not_active Not-in-force
- 2010-07-16 JP JP2012519888A patent/JP5872466B2/ja not_active Expired - Fee Related
- 2010-07-16 US US13/383,310 patent/US8920775B2/en not_active Expired - Fee Related
- 2010-07-16 IN IN1449DEN2012 patent/IN2012DN01449A/en unknown
- 2010-07-16 CA CA2768444A patent/CA2768444A1/en not_active Abandoned
-
2014
- 2014-12-22 US US14/579,552 patent/US20150202336A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8920775B2 (en) | 2014-12-30 |
US20150202336A1 (en) | 2015-07-23 |
AU2010272957A1 (en) | 2012-03-08 |
EP2453927A1 (en) | 2012-05-23 |
WO2011006510A1 (en) | 2011-01-20 |
CA2768444A1 (en) | 2011-01-20 |
EP2453927B1 (en) | 2019-05-15 |
EP2453927A4 (en) | 2013-01-23 |
AU2010272957B2 (en) | 2016-03-03 |
JP2012533523A (ja) | 2012-12-27 |
US20120213698A1 (en) | 2012-08-23 |
JP5872466B2 (ja) | 2016-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN01449A (ru) | ||
You et al. | Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma–A case-matched comparison | |
Castaldi et al. | Can “early” and “late” 18F-FDG PET–CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? | |
WO2008008483A3 (en) | Dendrimer based compositions and methods of using the same | |
WO2009009203A3 (en) | Dendrimer based compositions and methods of using the same | |
WO2010120905A3 (en) | Novel nano-probes for molecular imaging and targeted therapy of diseases | |
NZ605674A (en) | X-ray imaging at low contrast agent concentrations and/or low dose radiation | |
EP3208615A3 (en) | Uses of labeled hsp90 inhibitors | |
MX2015001716A (es) | Niclosamida para el tratamiento de tumores solidos. | |
NZ710436A (en) | Biospecific agents for bone | |
Li et al. | Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients | |
WO2012109466A3 (en) | Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent | |
WO2015158652A8 (en) | S100p and hyluronic acid as biomarkers for metastatic breast cancer | |
CO6382138A2 (es) | N-cadherina: blanco para diagnosis y terapia de cáncer | |
GB201121914D0 (en) | Method for patient selection | |
De Waele et al. | Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT | |
Demirci et al. | The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer | |
MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
MX2008016493A (es) | Metodo para la deteccion de diagnostico de cancer que implica cebadores y sondas para la deteccion especifica del marcador mage-3. | |
WO2007136856A3 (en) | Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor | |
UA56157U (ru) | Способ предоставления помощи больным с пост-травматической отоликвореей в остром периоде черепно-мозговой травмы при переломах височной кости | |
UA60606U (ru) | Способ стереотаксической биопсии очаговых образований головного мозга глубинной локализации | |
Emmett et al. | Imaging for melanoma and non-melanoma skin cancers | |
Iwahashi et al. | A Case of MALT Lymphoma Occurrence in the False Vocal Cord | |
Gelezhe et al. | CURRENT CRITERIA OF RADIAL DIAGNOSTICS TO ASSESS THE EFFECTIVENESS OF SPECIFIC CANCER TREATMENT |